Skip to main content
. Author manuscript; available in PMC: 2022 Aug 9.
Published in final edited form as: Head Neck. 2021 Apr 15;43(8):2434–2444. doi: 10.1002/hed.26708

TABLE 2.

Patients who experienced adverse outcomes

Age at
diagnosis
Sex Smoking
status
Subsite T
Classification
N
Classification
(AJCC
8th ed.)
N
Classification
(AJCC
7th ed.)
ENE PNI Overall
stage
ECOG risk
class
Re-
resection
Final
margin
(mm)
Event Time to
event
(months)
Salvage
therapy
Disease
status
61 Male Never Base of tongue T1 N1 N2a N0 No I Low No Negative Local recurrence 18 Surgery NED
59 Female Current Tonsil T1 N0 N0 N/A No I Low Yes 4–4.9 Local recurrence 17 Radiation NED
53 Male Never Base of tongue T1 N1 N2a N0 No I Intermediate No Close Regional recurrence 27 Surgery NED
60 Male Current Base of tongue T1 N2 N2b Yes Yes II High Yes Negative Regional recurrence 7 Chemoradiation NED
57 Male Never Tonsil T1 N1 N1 N0 No I Low No >5 Regional recurrence 24 Chemoradiation NED
54 Male Former Base of tongue T1 N1 N1 N0 No I Low No >5 Distant metastasis 27 Chemotherapy Active disease
69 Male Never Base of tongue T1 N0 N0 N/A No I Intermediate Yes 1–1.9 Distant metastasis 41 Chemotherapy Active disease
74 Male Former Tonsil T2 N0 N0 N/A No I Intermediate No 1–1.9 Distant metastasis, death 12 Chemoradiation Deceased
88 Male Unknown Base of tongue T2 N2 N2b No No II High No Close Death 8 N/A Deceased
88 Male Current Base of tongue T1 N1 N2a No Unknown I Intermediate No Close Death 28 N/A Deceased
63 Male Former Tonsil T1 N1 N2b Yes No I High No 2–2.9 Death 6 N/A Deceased

Abbreviations: AJCC, American Joint Committee on Cancer; ECOG, Eastern Cooperative Oncology Group; ENE, extranodal extension; PNI, perineural invasion.